What is he best known for?
The fields of study he is best known for:
- Neurotransmitter
- Dopamine
- Agonist
His primary areas of study are Internal medicine, Endocrinology, Pharmacology, Glutamate receptor and Neuroscience.
Agonist, Neurotransmitter, Dopamine and NMDA receptor are the subjects of his Internal medicine studies.
His study looks at the relationship between Neurotransmitter and topics such as Microdialysis, which overlap with Globus pallidus.
His study in Modafinil and Acetylcholine is carried out as part of his Pharmacology studies.
His Glutamate receptor research includes themes of Hippocampal formation, Cannabinoid and Glutamic acid.
His studies in Neuroscience integrate themes in fields like Metabotropic glutamate receptor 5, Galanin receptor and Heteroreceptor.
His most cited work include:
- Δ9-Tetrahydrocannabinol decreases extracellular GABA and increases extracellular glutamate and dopamine levels in the rat prefrontal cortex: an in vivo microdialysis study (185 citations)
- Receptor–receptor interactions within receptor mosaics. Impact on neuropsychopharmacology (165 citations)
- Prenatal exposure to a cannabinoid agonist produces memory deficits linked to dysfunction in hippocampal long-term potentiation and glutamate release (141 citations)
What are the main themes of his work throughout his whole career to date?
Sergio Tanganelli mainly focuses on Internal medicine, Endocrinology, Neuroscience, Pharmacology and Glutamate receptor.
His Endocrinology research incorporates themes from Cholecystokinin and Antagonist, Receptor antagonist, Cannabinoid receptor.
His Neuroscience research includes elements of Metabotropic glutamate receptor 5, Parkinson's disease and Neurotransmission.
His Pharmacology research is multidisciplinary, incorporating elements of Agonist, GABAergic, Prazosin and GABAA receptor.
His Glutamate receptor research is multidisciplinary, relying on both NMDA receptor and Cannabinoid.
His study looks at the intersection of Microdialysis and topics like Striatum with Globus pallidus.
He most often published in these fields:
- Internal medicine (42.21%)
- Endocrinology (42.21%)
- Neuroscience (37.01%)
What were the highlights of his more recent work (between 2010-2020)?
- Neuroscience (37.01%)
- Dopamine receptor D2 (24.68%)
- Pharmacology (36.36%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Neuroscience, Dopamine receptor D2, Pharmacology, Glutamate receptor and Heteroreceptor.
Sergio Tanganelli has researched Neuroscience in several fields, including Heteromer and Parkinson's disease.
His Dopamine receptor D2 research also works with subjects such as
- Adenosine, which have a strong connection to Striatum,
- Neurochemical which intersects with area such as Neurotransmitter.
His studies deal with areas such as Agonist, Receptor, Anxiolytic, Neurotoxicity Syndrome and Adenosine A2A receptor as well as Pharmacology.
The study incorporates disciplines such as Cerebral cortex, Endocrinology and Neurotransmission in addition to Glutamate receptor.
Sergio Tanganelli interconnects Dopamine receptor, Ventral striatum and Allosteric regulation in the investigation of issues within Heteroreceptor.
Between 2010 and 2020, his most popular works were:
- Understanding the Functional Plasticity in Neural Networks of the Basal Ganglia in Cocaine Use Disorder: A Role for Allosteric Receptor-Receptor Interactions in A2A-D2 Heteroreceptor Complexes. (134 citations)
- Understanding the Role of GPCR Heteroreceptor Complexes in Modulating the Brain Networks in Health and Disease. (67 citations)
- GPCR heteromers and their allosteric receptor-receptor interactions. (67 citations)
In his most recent research, the most cited papers focused on:
- Neurotransmitter
- Dopamine
- Agonist
His primary scientific interests are in Neuroscience, Agonist, Dopamine receptor D2, Allosteric regulation and Heteroreceptor.
His Neuroscience study frequently links to adjacent areas such as Glutamate receptor.
To a larger extent, Sergio Tanganelli studies Internal medicine with the aim of understanding Glutamate receptor.
His work investigates the relationship between Agonist and topics such as Pharmacology that intersect with problems in Quinpirole.
His Dopamine receptor D2 study which covers Metabotropic glutamate receptor 5 that intersects with Scaffold protein, Autoreceptor, gamma-Aminobutyric acid and Adenosine A2A receptor.
His Receptor study combines topics from a wide range of disciplines, such as Extracellular, Microdialysis and Striatum.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
